Healthcare provider profile · identity verified

Gilbert E Greene, D.O.

Family Practice · STOCKTON, CA · NPI 1124007430

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	286	41
Atorvastatin Calcium	Atorvastatin Calcium	240	66
Amlodipine Besylate	Amlodipine Besylate	164	54
Lisinopril	Lisinopril	164	40
Gabapentin	Gabapentin	150	35
Furosemide	Furosemide	133	34
Metformin Hcl	Metformin Hcl	126	33
Losartan Potassium	Losartan Potassium	115	33
Levothyroxine Sodium	Levothyroxine Sodium	108	28
Omeprazole	Omeprazole	106	31
Tamsulosin Hcl	Tamsulosin Hcl	102	31
Baclofen	Baclofen	73	23
Metoprolol Succinate	Metoprolol Succinate	70	25
Tramadol Hcl	Tramadol Hcl	70	24
Clonazepam	Clonazepam	69	suppressed
Potassium Chloride	Potassium Chloride	69	18
Albuterol Sulfate Hfa	Albuterol Sulfate	68	21
Allopurinol	Allopurinol	64	14
Duloxetine Hcl	Duloxetine Hcl	63	suppressed
Eliquis	Apixaban	61	16
Lorazepam	Lorazepam	57	15
Sertraline Hcl	Sertraline Hcl	52	12
Glipizide	Glipizide	51	13
Alendronate Sodium	Alendronate Sodium	45	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	45	16
Levetiracetam	Levetiracetam	42	suppressed
Alprazolam	Alprazolam	41	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	41	14
Metoprolol Tartrate	Metoprolol Tartrate	37	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	25
Mirtazapine	Mirtazapine	34	suppressed
Azithromycin	Azithromycin	32	27
Carvedilol	Carvedilol	32	suppressed
Ramipril	Ramipril	32	suppressed
Ibuprofen	Ibuprofen	31	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Famotidine	Famotidine	29	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	29	14
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Atenolol	Atenolol	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Simvastatin	Simvastatin	26	suppressed
Colchicine	Colchicine	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Trazodone Hcl	Trazodone Hcl	24	suppressed
Finasteride	Finasteride	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	11
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	22	suppressed
Temazepam	Temazepam	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	13
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Carisoprodol	Carisoprodol	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Spironolactone	Spironolactone	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Benztropine Mesylate	Benztropine Mesylate	15	suppressed
Ozempic	Semaglutide	15	suppressed
Klor-Con M15	Potassium Chloride	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Prednisone	Prednisone	12	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Naproxen	Naproxen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error